ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $415,000 | +501.4% | 18,900 | +83.5% | 0.08% | +372.2% |
Q1 2016 | $69,000 | -46.9% | 10,300 | -32.0% | 0.02% | -48.6% |
Q4 2015 | $130,000 | +4.0% | 15,150 | -33.6% | 0.04% | 0.0% |
Q3 2015 | $125,000 | -51.2% | 22,800 | -49.4% | 0.04% | -46.2% |
Q2 2015 | $256,000 | +12.3% | 45,100 | -9.8% | 0.06% | +20.4% |
Q1 2015 | $228,000 | 0.0% | 50,000 | 0.0% | 0.05% | 0.0% |
Q4 2014 | $228,000 | -68.7% | 50,000 | -44.1% | 0.05% | -69.0% |
Q3 2014 | $728,000 | -17.0% | 89,500 | -1.9% | 0.17% | -17.9% |
Q2 2014 | $877,000 | -12.5% | 91,200 | +7.4% | 0.21% | -12.8% |
Q1 2014 | $1,002,000 | +25.6% | 84,900 | +64.2% | 0.24% | +23.4% |
Q4 2013 | $798,000 | – | 51,700 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |